207 related articles for article (PubMed ID: 21054933)
1. Human bone marrow stromal cells and skin fibroblasts inhibit natural killer cell proliferation and cytotoxic activity.
Pradier A; Passweg J; Villard J; Kindler V
Cell Transplant; 2011; 20(5):681-91. PubMed ID: 21054933
[TBL] [Abstract][Full Text] [Related]
2. Immunological aspects of allogeneic and autologous mesenchymal stem cell therapies.
Hoogduijn MJ; Roemeling-van Rhijn M; Korevaar SS; Engela AU; Weimar W; Baan CC
Hum Gene Ther; 2011 Dec; 22(12):1587-91. PubMed ID: 21732766
[TBL] [Abstract][Full Text] [Related]
3. Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells.
Krampera M; Cosmi L; Angeli R; Pasini A; Liotta F; Andreini A; Santarlasci V; Mazzinghi B; Pizzolo G; Vinante F; Romagnani P; Maggi E; Romagnani S; Annunziato F
Stem Cells; 2006 Feb; 24(2):386-98. PubMed ID: 16123384
[TBL] [Abstract][Full Text] [Related]
4. Proteolytic activation of the cytotoxic phenotype during human NK cell development.
Meade JL; Wilson EB; Holmes TD; de Wynter EA; Brett P; Straszynski L; Ballard PA; Trapani JA; McDermott MF; Cook GP
J Immunol; 2009 Jul; 183(2):803-13. PubMed ID: 19570824
[TBL] [Abstract][Full Text] [Related]
5. Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4.
Keever CA; Pekle K; Gazzola MV; Collins NH; Bourhis JH; Gillio A
J Immunol; 1989 Nov; 143(10):3241-9. PubMed ID: 2809200
[TBL] [Abstract][Full Text] [Related]
6. [Experimental study on IL-2- and IL-15 application in allogeneic hematopoietic stem cell transplantation].
Chen GH; Wu DP; Sun AN; Yang MZ; Wang Y; Tang XW; Chang HR; Feng YF; Zhu ZL
Zhonghua Xue Ye Xue Za Zhi; 2008 Aug; 29(8):526-30. PubMed ID: 19112915
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells.
Rasmusson I; Ringdén O; Sundberg B; Le Blanc K
Transplantation; 2003 Oct; 76(8):1208-13. PubMed ID: 14578755
[TBL] [Abstract][Full Text] [Related]
8. Interactions between human mesenchymal stem cells and natural killer cells.
Sotiropoulou PA; Perez SA; Gritzapis AD; Baxevanis CN; Papamichail M
Stem Cells; 2006 Jan; 24(1):74-85. PubMed ID: 16099998
[TBL] [Abstract][Full Text] [Related]
9. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
[TBL] [Abstract][Full Text] [Related]
10. Endogenous IL-2 production by natural killer cells maintains cytotoxic and proliferative capacity following retroviral-mediated gene transfer.
Miller JS; Tessmer-Tuck J; Blake N; Lund J; Scott A; Blazar BR; Orchard PJ
Exp Hematol; 1997 Oct; 25(11):1140-8. PubMed ID: 9328450
[TBL] [Abstract][Full Text] [Related]
11. Comparison of natural killer activity of human bone marrow and blood cells in cultures containing IL-2, IL-7 and IL-12.
Wong EK; Eaves C; Klingemann HG
Bone Marrow Transplant; 1996 Jul; 18(1):63-71. PubMed ID: 8831997
[TBL] [Abstract][Full Text] [Related]
12. Effect of interleukin-12 on antitumor activity of human umbilical cord blood and bone marrow cytotoxic cells.
Condiotti R; Nagler A
Exp Hematol; 1998 Jul; 26(7):571-9. PubMed ID: 9657131
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow mesenchymal stem cells reduce the antitumor activity of cytokine-induced killer/natural killer cells in K562 NOD/SCID mice.
Li Y; Qu YH; Wu YF; Wang XP; Wei J; Huang WG; Zhou DH; Fang J; Huang K; Huang SL
Ann Hematol; 2011 Aug; 90(8):873-85. PubMed ID: 21234566
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal cells inhibit expansion but not cytotoxicity exerted by gamma-delta T cells.
Petrini I; Pacini S; Petrini M; Fazzi R; Trombi L; Galimberti S
Eur J Clin Invest; 2009 Sep; 39(9):813-8. PubMed ID: 19522834
[TBL] [Abstract][Full Text] [Related]
15. Antitumor treatment using interleukin- 12-secreting marrow stromal cells in an invasive glioma model.
Hong X; Miller C; Savant-Bhonsale S; Kalkanis SN
Neurosurgery; 2009 Jun; 64(6):1139-46; discussion 1146-7. PubMed ID: 19487894
[TBL] [Abstract][Full Text] [Related]
16. Human mesenchymal stromal cells transiently increase cytokine production by activated T cells before suppressing T-cell proliferation: effect of interferon-γ and tumor necrosis factor-α stimulation.
Cuerquis J; Romieu-Mourez R; François M; Routy JP; Young YK; Zhao J; Eliopoulos N
Cytotherapy; 2014 Feb; 16(2):191-202. PubMed ID: 24438900
[TBL] [Abstract][Full Text] [Related]
17. Immune protection function of multipotent mesenchymal stromal cells: role of transforming growth factor-β1.
Zhao ZG; Cao Z; Xu W; Sun L; You Y; Li F; Li QB; Zou P
Cancer Invest; 2012 Nov; 30(9):646-56. PubMed ID: 23020627
[TBL] [Abstract][Full Text] [Related]
18. Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell-therapy approaches: further insights in the search for a fetal calf serum substitute.
Bernardo ME; Avanzini MA; Perotti C; Cometa AM; Moretta A; Lenta E; Del Fante C; Novara F; de Silvestri A; Amendola G; Zuffardi O; Maccario R; Locatelli F
J Cell Physiol; 2007 Apr; 211(1):121-30. PubMed ID: 17187344
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow-derived mesenchymal stromal cells are attracted by multiple myeloma cell-produced chemokine CCL25 and favor myeloma cell growth in vitro and in vivo.
Xu S; Menu E; De Becker A; Van Camp B; Vanderkerken K; Van Riet I
Stem Cells; 2012 Feb; 30(2):266-79. PubMed ID: 22102554
[TBL] [Abstract][Full Text] [Related]
20. NKG2D and natural cytotoxicity receptors are involved in natural killer cell interaction with self-antigen presenting cells and stromal cells.
Poggi A; Prevosto C; Zancolli M; Canevali P; Musso A; Zocchi MR
Ann N Y Acad Sci; 2007 Aug; 1109():47-57. PubMed ID: 17785290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
